U.S. Wireless Telecom Stock News

SolarEdge Technologies stock sits in an awkward spot for valuation focused investors, with a sharp 81.2% decline over the past 5 years set against recent share price strength and a valuation score that points to a mixed picture rather than a clear bargain or clear overvaluation. Over 5 years, SolarEdge Technologies has fallen 81.2%, which means anyone who bought and held through that period has seen most of their capital eroded and may now be reassessing what price makes sense. Recent...

Oil above $100 a barrel and US Treasury yields above 4.7% on the 10-year and 5.18% on the 30-year are not just headlines; they directly influence company costs, financing, and valuations. Some stocks can potentially benefit when rates rise or energy prices spike, while others may face pressure from higher fuel bills or more expensive debt. This article walks through three stocks exposed to these twin shocks, explaining one case where the backdrop could be a tailwind and two where it may be a...

Simmons First National Corporation recently reported past second-quarter 2026 results, with net interest income of US$200.63 million, net income of US$66.69 million and net loan charge-offs of US$9.12 million, all measured against the same period a year earlier. The bank also completed a repurchase of 700,000 shares for US$15.06 million, a capital allocation move that sits alongside higher earnings and lower loan charge-offs to shape how investors assess its financial profile. We’ll now...

In July 2026, TTM Technologies presented its aerospace, defense, and advanced electronics capabilities at the Farnborough International Airshow in the United Kingdom, highlighting its mission systems, RF components, and complex PCB solutions for global customers. The event underscored TTM's growing role in supplying high-end electronics for AI data center infrastructure and mission-critical defense hardware, reinforcing its position in these specialized markets. We’ll now examine how TTM’s...

Tariffs are moving again, and that can quickly change the risk and reward profile for U.S. manufacturers. With new charges on Brazilian and Canadian imports, ongoing levies on metals, autos, timber and semiconductors, and a fresh 100% tariff on many pharmaceuticals, investors are asking which domestic producers might stand to benefit. This article looks at stocks from a U.S. Domestic Manufacturing Stocks screener that are closely exposed to these tariff shifts, and will walk through 3...

Axsome Therapeutics reported that the FDA has accepted its New Drug Application for AXS-12 for the treatment of cataplexy in narcolepsy. The FDA does not plan to hold an advisory committee meeting as part of the review. The filing acceptance marks a key regulatory step for AXS-12, a potential option for a serious sleep disorder with unmet medical need. For Axsome Therapeutics (NasdaqGM:AXSM), this regulatory milestone arrives with the stock trading around $239.62 and a very large 3 year and...

United Rentals stock has delivered a strong 229.4% return over the past five years, yet its valuation checks are sending mixed messages, with the Discounted Cash Flow (DCF) intrinsic value estimate pointing to a premium while market multiples lean the other way. For investors trying to assess what the current US$1,035.06 share price really reflects, the split between these frameworks is central. Over five years United Rentals has returned 229.4%, which puts extra focus on whether recent...

With inflation, energy prices and interest rate expectations all pulling markets in different directions, many investors are looking for leaders whose interests are closely tied to long term outcomes rather than short term headlines. Founder led companies can fit that brief, as founders often have more of their own wealth, reputation and time invested in the business. This article looks at a curated Founder Led Companies screener that focuses on leaders who are personally committed to...

Houlihan Lokey stock has delivered a 76.5% total return over the past five years, yet its current valuation picture is split, with the Excess Returns intrinsic value estimate pointing to upside while earnings based multiples suggest the shares trade at a richer level. Over five years, a 76.5% return suggests Houlihan Lokey has rewarded patient shareholders, even though the share price has recently been under pressure. For a specialist advisory firm like Houlihan Lokey, expectations for...

Enovix Corporation announced that Dr. Michael Vyvoda, a former Apple Product Operations Director who helped scale AirPods manufacturing, joined as Chief Operating Officer on July 29, 2026, taking charge of global manufacturing, supply chain and operations engineering across Malaysia, Korea and India. By consolidating key operations leaders under a single COO with deep high-volume manufacturing experience, Enovix is signaling a reinforced focus on execution as it expands global...

Nu Holdings has delivered an 84.8% return over the past three years, yet its valuation signals are split, with an Excess Returns intrinsic value estimate suggesting about 11.1% upside while market multiples lean toward the stock looking expensive. Nu Holdings' 84.8% return over three years puts recent shareholders in a strong position. This raises the question of how much upside is left from here. Recent progress on full banking licenses in Brazil and Mexico can support expectations for...

RH stock has had a difficult run over the past few years, and the latest valuation work points to shares trading at a premium, with both a Discounted Cash Flow (DCF) intrinsic value estimate and earnings multiples indicating the stock screens as overvalued rather than as a clear bargain. RH has declined about 74.0% over the past five years, which means long term shareholders are still sitting on sizeable losses despite shorter term rebounds. Expectations for stronger earnings growth...

Vistra stock has delivered an extremely strong 5 year return, but after that run the valuation screens now point to something closer to a middle ground than a clear bargain or clear excess. Over the last 5 years, Vistra has returned about 8.4x an initial investment, which puts extra focus on whether the current price still reflects its fundamentals. Growing attention on power demand from data centers and AI infrastructure can support long term earnings expectations for Vistra, while...

Big Tech’s rush to issue AI-related debt is pouring hundreds of billions into the bond market, helping push long-term Treasury yields toward 5% and making risk free income look more appealing. That shift can weigh on share prices; yet it also shines a spotlight on high-yield dividend stocks with at least 3% yields, moderate risk scores, and manageable leverage. For investors who want income but are cautious about heavy borrowing costs, this screen surfaces companies that may handle higher...

Lowe's Companies has had a soft start to 2026, with the share price down 17.2% year to date, while both intrinsic value checks and market multiples currently point to the stock trading below what its cash flows may justify. For investors, that sets up a clear tension between recent share price weakness and valuation signals that lean supportive. The stock has declined 17.2% so far this year, which means sentiment has cooled even as the long term business case is still being...

Resignation of Asana’s Chief Accounting Officer Asana (ASAN) recently disclosed that Chief Accounting Officer and Principal Accounting Officer Veronica Sosa has resigned, with her departure effective August 7, 2026, following a transition period in her current role. The company stated that Sosa’s resignation did not arise from any disagreements with Asana regarding operations, policies, practices, or accounting matters, which may guide how investors interpret this leadership change. See our...

Waste Management (NYSE:WM) reported a strong 2025, highlighting growth in renewable natural gas and recycling. The company announced a 14.5% dividend increase for 2026. Waste Management also introduced a new US$3b share repurchase program. For investors watching the waste and recycling sector, Waste Management stands out as a large, vertically integrated operator with exposure to collection, landfill, recycling, and renewable natural gas. Recent company updates point to meaningful activity...

Many MapLight Therapeutics, Inc. ( NASDAQ:MPLT ) insiders ditched their stock over the past year, which may be of...

Over the last 7 days, the United States market has dropped 1.4%, yet it remains up 16% over the past year, with earnings anticipated to grow by 18% annually in the coming years. In this context, identifying stocks that might be trading below their estimated intrinsic values can offer investors potential opportunities for long-term growth amidst fluctuating market conditions.

Over the last 7 days, the United States market has experienced a 1.4% drop, yet it remains up by 16% over the past year, with earnings forecasted to grow by 18% annually. In this context, growth companies with high insider ownership can be particularly appealing as they often indicate strong confidence from those closest to the company and may align well with anticipated earnings growth.

Over the last 7 days, the market has dropped 1.4%, but it is up 16% over the past year, with earnings forecasted to grow by 18% annually. For investors willing to explore beyond well-known stocks, penny stocks—often smaller or newer companies—can be full of surprises and remain a relevant investment area despite being a somewhat outdated term. In this article, we highlight three penny stocks that stand out for their financial strength and potential for growth.

Cboe Global Markets has delivered a strong 159.8% return over the past 5 years. At a recent close of US$281.80 the company screens as expensive on several valuation checks, which raises the question of how much of its quality and growth story is already reflected in the price. A 159.8% return over 5 years suggests Cboe Global Markets has rewarded long term shareholders, so the current valuation needs to be judged against already substantial gains. Coverage highlighting Cboe Global Markets'...

Avanos Medical (AVNS) continues to trade around $24.98, drawing attention from investors who are weighing its medical device portfolio against mixed financial metrics, including modest annual revenue growth and a reported net loss. See our latest analysis for Avanos Medical. Over the past year Avanos Medical’s share price return has moved sharply higher, with a year to date share price return of 123.43% and a 1 year total shareholder return of 106.28%. However, the 5 year total shareholder...

Alexander's (ALX) continues to draw attention after recent share price moves alongside its latest reported figures, including US$211.68 million in revenue and US$20.57 million in net income from its New York focused real estate portfolio. See our latest analysis for Alexander's. At a latest share price of US$276.53, Alexander's has seen a 26.35% year to date share price return and a 16.80% total shareholder return over the past year, with the recent 1 day decline of 3.35% tempering what has...